ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0,125
0,01
(8,70%)
Geschlossen 30 November 10:00PM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,125
Gebot
0,12
Fragen
0,125
Volumen
616.500
0,11 Tagesbereich 0,13
0,06 52-Wochen-Bereich 0,17
Marktkapitalisierung
Handelsende
0,115
Handelsbeginn
0,12
Letzte Trade
5000
@
0.125
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
89.053
Ausgegebene Aktien
131.844.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,00
Gewinn pro Aktie (EPS)
-0,04
Erlöse
2,82M
Nettogewinn
-5,27M

Über Kane Biotech Inc

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Hauptsitz
Winnipeg, Manitoba, Can
Gegründet
-
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX Venture Börse with ticker KNE. The last closing price for Kane Biotech was $0,12. Over the last year, Kane Biotech shares have traded in a share price range of $ 0,06 to $ 0,17.

Kane Biotech currently has 131.844.000 shares in issue. The market capitalisation of Kane Biotech is $15,16 million. Kane Biotech has a price to earnings ratio (PE ratio) of -3.00.

KNE Neueste Nachrichten

Kane Biotech Announces Third Quarter 2024 Financial Results

WINNIPEG, Manitoba, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its third quarter 2024 financial...

Kane Biotech Announces Change in US Distribution Partner for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech” or “Kane”) announces today that BioStem Technologies Inc...

Kane Biotech to Release Third Quarter 2024 Financial Results on November 28, 2024

WINNIPEG, Manitoba, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will release its third quarter 2024 financial results after market close on...

Kane Biotech Announces Health Canada Approval of revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of...

Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr...

Kane Biotech Announces Agreement to Acquire FB Dermatology

WINNIPEG, Manitoba, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that it has entered into a binding term sheet...

Kane Biotech Announces Donation of revyve™ Antimicrobial Wound Gel to Ukraine

WINNIPEG, Manitoba, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it is donating 2,000 ounces of revyve™ Antimicrobial...

Kane Biotech Announces Exclusive Distribution Agreement With XSONX

WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has signed an exclusive five year distribution...

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

Kane Biotech Announces Attendance at Upcoming Wound Care Conferences

WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.018.695652173910.1150.130.105306900.11408765CS
4-0.005-3.846153846150.130.130.1605030.11259838CS
12-0.005-3.846153846150.130.1450.1890530.1240693CS
26-0.005-3.846153846150.130.170.1937620.13743271CS
520.0566.66666666670.0750.170.061066120.12715088CS
156-0.04-24.24242424240.1650.170.05665130.11632453CS
260-0.005-3.846153846150.130.260.05676410.13568635CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ENTGEntourage Health Corp
$ 0,015
(200,00%)
2,18M
ACAP.PAtlas One Capital Corporation
$ 0,015
(200,00%)
221,8k
SSESilver Spruce Resources Inc
$ 0,01
(100,00%)
18,01k
XCAP.PExelerate Capital Corp
$ 0,05
(66,67%)
129k
POOLPool Safe Inc
$ 0,04
(60,00%)
158,3k
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
52,11k
OSIXOceansix Future Paths Ltd
$ 0,005
(-50,00%)
2,12M
JHCJinhua Capital Corporation
$ 0,005
(-50,00%)
140k
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
130k
MDK.PMDK Acquisition Inc
$ 0,05
(-50,00%)
5k
EGTEguana Technologies Inc
$ 0,01
(0,00%)
2,55M
ENTGEntourage Health Corp
$ 0,015
(200,00%)
2,18M
OSIXOceansix Future Paths Ltd
$ 0,005
(-50,00%)
2,12M
RIORio2 Limited New
$ 0,63
(-4,55%)
2,11M
GBUGabriel Resources Ltd
$ 0,015
(0,00%)
2,02M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock